Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Sex Transm Dis ; 48(8S): S40-S43, 2021 08 01.
Article in English | MEDLINE | ID: mdl-33967232

ABSTRACT

ABSTRACT: This evaluation describes an increase in reported drug-related risk behaviors among females who are diagnosed with early syphilis over a 5-year span in New York State, excluding New York City. Integrating sexually transmitted infection prevention efforts with harm reduction services may help decrease syphilis rates in areas where drug-related risk behavior rates are high.


Subject(s)
HIV Infections , Pharmaceutical Preparations , Sexually Transmitted Diseases , Syphilis , Female , Humans , New York City/epidemiology , Risk-Taking , Sexually Transmitted Diseases/diagnosis , Sexually Transmitted Diseases/epidemiology , Syphilis/diagnosis , Syphilis/epidemiology
2.
Sex Transm Dis ; 47(11): 733-738, 2020 11.
Article in English | MEDLINE | ID: mdl-33045162

ABSTRACT

BACKGROUND: From November 2014 to May 2016, 57 local health departments in New York State (NYS) excluding New York City were offered a performance incentive (PI) to promote adherence to federally recommended treatment guidelines for gonorrhea. The rationale of the PI was to delay antibiotic resistance and disrupt transmission through attaining a high percentage of treatment adherence. METHODS: Surveillance data from the NYS Communicable Disease Electronic Surveillance System were used for analysis. We evaluated adherence per Centers for Disease Control and Prevention sexually transmitted diseases treatment guidelines for persons 12 years and older reported with uncomplicated gonorrhea during 4 time frames: Pre-PI, PI One, PI Two, and Post-PI. We measured adherence per the Centers for Disease Control and Prevention sexually transmitted disease treatment guidelines during each respective time frame and conducted χ tests to test for the association between treatment adequacy and time frame. RESULTS: During the Pre-PI, treatment was adequate in 82.0% of persons diagnosed with gonorrhea. After program implementation, treatment adequacy increased significantly (92.1% of diagnosed persons during PI One, 90.4% during PI Two, and 90.5% during the Post-PI; P ≤ 0.0001). The most common reason for inadequate or missing treatment was patient lost to follow-up. CONCLUSIONS: Public health intervention by the NYS Department of Health improved local health department adherence to federally recommended gonorrhea treatment guidelines, and improvements were maintained after the completion of the PI.


Subject(s)
Anti-Bacterial Agents/pharmacology , Azithromycin/therapeutic use , Ceftriaxone/therapeutic use , Gonorrhea/drug therapy , Guideline Adherence/statistics & numerical data , Neisseria gonorrhoeae/drug effects , Drug Resistance, Microbial , Gonorrhea/diagnosis , Gonorrhea/epidemiology , Humans , Microbial Sensitivity Tests , Neisseria gonorrhoeae/isolation & purification , New York City/epidemiology , Population Surveillance , Sentinel Surveillance , United States
SELECTION OF CITATIONS
SEARCH DETAIL
...